Their buy-back announcements don't do a thing to the share price,given their track record in this regard.Please privatise YBR Mr Bouris and get me out of my misery.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025